Related Experiment Video

Updated: Aug 15, 2026

Mutagenesis and Analysis of Genetic Mutations in the GC-rich KISS1 Receptor Sequence Identified in Humans with Reproductive Disorders
12:49

Mutagenesis and Analysis of Genetic Mutations in the GC-rich KISS1 Receptor Sequence Identified in Humans with Reproductive Disorders

Published on: September 4, 2011

A point mutation uncouples human interleukin-1 beta biological activity and receptor binding

L Gehrke1, S A Jobling, L S Paik

  • 1Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge 02139.

The Journal of Biological Chemistry
|April 15, 1990
PubMed

Insights

Mutating interleukin-1 beta (IL-1 beta) protein reduced its bioactivity significantly more than its receptor binding. This suggests IL-1 beta binding is necessary but not sufficient for biological activity, impacting antagonist design.

Area of Science:

  • Immunology
  • Molecular Biology
  • Biochemistry

Background:

  • Interleukin-1 (IL-1) proteins mediate diverse biological activities.
  • The precise molecular mechanisms linking IL-1 receptor binding to downstream signaling remain incompletely understood.

Purpose of the Study:

  • To investigate the relationship between IL-1 beta receptor binding and its biological activity.
  • To elucidate the molecular events critical for IL-1 beta-mediated signal transduction.

Main Methods:

  • Site-directed mutagenesis was used to create a mutant human IL-1 beta protein (Arg127 to Gly127).
  • The bioactivity and receptor binding affinity of the wild-type and mutant IL-1 beta proteins were quantitatively assessed.

Main Results:

  • The Arg127Gly mutation in IL-1 beta resulted in a 100-fold decrease in bioactivity.
  • Receptor binding affinity of the mutant IL-1 beta protein decreased by only 25% compared to wild-type.
  • The mutant IL-1 beta protein demonstrated a defect in initiating signal transduction events.

Conclusions:

  • IL-1 beta receptor binding is a necessary but insufficient prerequisite for eliciting biological activity.
  • Distinct molecular features of IL-1 beta govern receptor interaction and signal activation.
  • These findings have potential clinical implications for developing targeted IL-1 antagonists.

More Related Videos

An ELISA Based Binding and Competition Method to Rapidly Determine Ligand-receptor Interactions08:40

An ELISA Based Binding and Competition Method to Rapidly Determine Ligand-receptor Interactions

Published on: March 14, 2016

Identification of Functional Protein Regions Through Chimeric Protein Construction11:39

Identification of Functional Protein Regions Through Chimeric Protein Construction

Published on: January 8, 2019

Related Concept Videos

Mutations01:39

Mutations

Overview
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...